A Single Arm, Single Center, Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Neurofibromatosis 2
- Focus Therapeutic Use
- Acronyms AFINF2
- 22 May 2017 Status changed from active, no longer recruiting to completed.
- 01 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
- 29 Jan 2016 New source Identified and integrated (NCT01490476).